UK markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
279.910.00 (0.00%)
As of 03:59PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-637,324
-637,324
-3,627,535
4,254,257
3,814,229
Depreciation & amortisation
145,900
145,900
137,300
137,600
138,600
Stock-based compensation
61,300
61,300
60,900
51,200
41,600
Change in working capital
-432,800
-432,800
-1,610,000
1,143,100
1,088,900
Accounts receivable
11,400
11,400
-87,400
-20,400
-15,000
Inventory
-46,300
-46,300
-158,800
46,100
-52,100
Accounts payable
-51,800
-51,800
-94,200
69,900
124,700
Other working capital
218,263
218,263
80,290
535,718
476,408
Other non-cash items
-11,957
-11,957
22,147
8,664
4,572
Net cash provided by operating activities
374,943
374,943
194,447
669,464
584,972
Cash flows from investing activities
Investments in property, plant and equipment
-156,680
-156,680
-114,157
-133,746
-108,564
Acquisitions, net
0
0
-100,746
-125,516
-96,655
Purchases of investments
-689,041
-689,041
-2,060,238
-851,627
-248,457
Sales/maturities of investments
863,218
863,218
1,066,027
766,896
368,058
Other investing activities
-153,969
-
-
-453,440
-
Net cash used for investing activities
20,208
20,208
-1,207,593
-797,381
-69,894
Cash flows from financing activities
Debt repayment
-467
-467
-510
-3,020
-426,938
Common stock repurchased
-428,728
-428,728
-215,679
-49,998
-100,004
Other financing activities
-14,936
-14,936
-14,015
-23,043
-16,297
Net cash used provided by (used for) financing activities
-425,647
-425,647
973,576
-55,429
-523,041
Net change in cash
-30,175
-30,175
-36,589
-195,982
4,464
Cash at beginning of period
434,544
434,544
471,133
667,115
662,651
Cash at end of period
404,369
404,369
434,544
471,133
667,115
Free cash flow
Operating cash flow
374,943
374,943
194,447
669,464
584,972
Capital expenditure
-156,680
-156,680
-114,157
-133,746
-108,564
Free cash flow
218,263
218,263
80,290
535,718
476,408